STRONGER NEO-MINOPHAGEN C P Inj. 20mL - 30 ampoules (hepatitis)

What are Neo-Minophagen injections for hepatitis? 

Japanese medical practitioners conducted specialized research into the effectiveness of glycyrrhizin in treating patients with chronic liver diseases. This investigation was carried out over 60 years ago when the Japanese Pharmacopoeia incorporated Minophagen, a product highly recommended for liver inflammatory conditions. Minophagen comprises glycyrrhizin, along with the amino acids glycine and cysteine. Glycine serves to prevent pseudoaldosteronism, while cysteine acts as a detoxifying agent. Prolonged clinical trials were undertaken, involving 84 patients with chronic hepatic cirrhosis. They received 2-7 courses of Minophagen annually over a span of 2-16 years.

Over the subsequent 15-year monitoring period, only 21% of the patients who were administered Monophagen were diagnosed with cirrhosis. Notably, Minophagen finds utility in patients grappling with chronic hepatitis and subacute hepatic dysfunction. Impressively, this medication exhibits a 2.3-fold reduction in mortality rate (p<0.01). Additionally, the efficacy of this drug extends to the treatment of conditions such as eczema, dermatitis, hives, dermal pruritus, drug eruptions, toxicoderma, stomatitis, strophulus infantum, and phlyctenulosis.

Active principles: 

• Monoammonium Glycyrizinate 53 mg,
• Glycyrrhizin 40 mg,
• Glycine  400 mg,
• L-Cysteine Hydrochloride 20 mg

Amount: 30 ampoules * 20 ml

Maker: Eisai Co., Ltd., Minophagen Pharmaceutical Co. Ltd., Tokyo, Japan

Indications:

• eczema/dermatitis, 
• hives, 
• dermal pruritus, 
• drug eruption/toxicoderma, 
• stomatitis, 
• strophulus infantum, 
• phlyctenulosis, 
• abnormal hepatic function in patients with chronic hepatic diseases.

How to use

The solution should be injected into a vein or administered by intravenous infusion once a day. Your doctor should determine duration of treatment depending on your symptoms.

Contraindications: do not use for pregnant or breastfeeding women. Do not use for patients with aldosteronism, myopathy or hypokalemia.

Important information

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.